戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  fundamental consequences for the control of immunologic disease.
2 hese molecular defects cause hematologic and immunologic disease.
3 l opportunities associated with the onset of immunologic disease.
4 logical system development and function, and immunologic disease.
5 , autoimmune disease, and other allergic and immunologic diseases.
6 nteraction regulates pathogenesis in various immunologic diseases.
7 ons of IgG4 biology for its proposed role in immunologic diseases.
8 y of these loci are also associated to other immunologic diseases.
9 ved HPCs in the treatment of hematologic and immunologic diseases.
10 rated clinical benefit in both oncologic and immunologic diseases.
11 ence for the treatment of allergic and other immunologic diseases.
12 ially curative treatment for hematologic and immunologic diseases.
13 nd outcomes among patients with allergic and immunologic diseases.
14 inflammation and the pathobiology of diverse immunologic diseases.
15 herapeutic response in patients with genetic immunologic diseases.
16 ) that that can adversely affect allergy and immunologic diseases.
17 for understanding mechanisms of allergic and immunologic diseases.
18 f a wide assortment of viral, bacterial, and immunologic diseases, a therapeutic approach using sphin
19 ted in the pathobiology of many allergic and immunologic diseases, as well as host defense mechanisms
20 to be responsible for several distinct human immunologic diseases by directly affecting the ability o
21 d computational tools to investigate complex immunologic diseases by looking at the state of a system
22 mal dystrophy (APECED) syndrome is a complex immunologic disease caused by mutation of the autoimmune
23       MRL-lpr/lpr mice develop a distinctive immunologic disease characterized by accumulation of unu
24             Autoimmune retinopathy is a rare immunologic disease characterized by the presence of cir
25  seen major advances in the understanding of immunologic diseases, driven by preclinical animal model
26 n, but combine many challenges in pregnancy: immunologic diseases, hypertension, proteinuria, and kid
27         Primary exclusion criteria included: immunologic diseases, immune-suppressing medications, an
28 pression have been described for a number of immunologic diseases, including B-cell lymphomas.
29 notherapy aside from bladder cancer, and (c) immunologic diseases, including multiple sclerosis, type
30               The biological role of LRBA in immunologic disease is unknown.
31 ur solely because of parasitic, allergic, or immunologic diseases, it is usually the consequence of n
32                Asthma has been considered an immunologic disease mediated by T(H)2 cells and adaptive
33 cell death and survival, cell signaling, and immunologic disease pathways.
34  that may be relevant to the pathogenesis of immunologic disease states.
35 rganizing pneumonia and erythema nodosum are immunologic diseases that have not been reported to occu
36 nce health equity for patients with allergic/immunologic diseases through actions taken at the indivi
37                     Patients with concurrent immunologic diseases were more commonly positive for DRB